SCHEMBL25762177

SCHEMBL25762177

CC(C)C1CCC(C(C)C)C(CN(C)C)C1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.34
TRPM8 Q7Z2W7 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18616102 0.79 TRPA1 (0.32) TRPA1TRPM8
SCHEMBL25762180 0.76 TRPA1 (0.32) TRPA1TRPM8
SCHEMBL25762183 0.76 TRPA1 (0.36) TRPA1TRPM8
SCHEMBL23612748 0.74
SCHEMBL25832188 0.72 TRPA1 (0.36) TRPA1TRPM8
SCHEMBL14116089 0.69 TRPA1 (0.61) TRPA1TRPM8
SCHEMBL12418413 0.69
SCHEMBL20034835 0.69
SCHEMBL20009102 0.67
SCHEMBL9498905 0.67 TRPA1 (0.35) TRPA1TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203063-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES ERASCA, INC. 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203063-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES TYMS, TYMP, DHFR TRPA1 3963/4885TRPM8 4182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.